Trial intelligence / Profile preview

Xiapex vs Percutaneous Needle Fasciotomy for Dupuytren's Contracture

NCT02476461Phase 4Unknown

Sponsor
Oslo University Hospital
Start
Apr 2015
Primary completion
Apr 2016
Modality
Therapeutic Enzymes
Countries
1
01

Overview

Phase 4, randomised, open-label trial of collagenase clostridium histolyticum in Dupuytren's contracture (2 arms), sponsored by Oslo University Hospital. Primary endpoint: Contracture Size at 5 Years. Status: unknown.

02

Drugs

collagenase clostridium histolyticum
03

Conditions

Dupuytren's contracture

Beyond the preview

Go deeper on NCT02476461.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02476461.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call